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Abstract 
Halogen-free organophosphorus flame retardants are considered as replacements for the 
phased-out class of polybrominated diphenyl ethers (PBDEs). Toxicological information on 
new flame retardants however is still limited. Based on their excellent flame retardation 
potential, we selected three novel 9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide 
(DOPO)-derivatives and assessed their toxicological profile by a battery of in vitro test 
systems in order to provide toxicological information before their large-scale production and 
use. PBDE-99, applied as reference compound, exhibited distinct neuro-selective cytotoxicity 
at concentrations  10 µM. ETA-DOPO and EG-DOPO displayed adverse effects at 
concentrations > 10 µM in test systems reflecting the properties of human central and 
peripheral nervous system neurons, as well as in a set of non-neuronal cell types. DOPO and 
its derivative 6,6’-(ethane-1,2-diylbis(azanediyl))bis(6H-dibenzo[1,2]oxaphosphine 6-oxide 
(EDA-DOPO) were neither neurotoxic, nor generally cytotoxic, nor did they exhibit an 
influence on neural crest cell migration, inflammatory activation or the integrity of human 
skin equivalents at concentrations  400 µM. Furthermore no impact on algae growth and the 
viability of daphnids, could be detected up to 1000 mg/l (water soluble fraction).. Based on its 
superior flame retardation properties, its biophysical features suited for use in polyurethane 
foams, and its low cytotoxicity, EDA-DOPO emerges as a candidate for the replacement of 
currently applied flame retardants.  
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Introduction 
Flame retardants are added to a wide range of materials in order to lower the risk of 
uncontrolled ignition and for the reduction of combustion rates. In recent years, the class of 
polybrominated diethyl ether retardants has been phased out, based on a growing 
understanding of their abundant prevalence in the environment and their persistence and 
bioaccumulation in the food chain (Covaci et al. 2011; Shaw et al. 2010; Hites et al. 2004). A 
developing number of observations indicated adverse influences of polybrominated flame 
retardants on endocrine functions mediated e.g. by thyroid-, androgen-, and estrogen-
signaling pathways (Zhou et al. 2002; Li et al. 2013; Stroker et al. 2005), but also on kidney 
and liver integrity (Albina et al. 2010), the cholinergic system (Viberg et al. 2002), neuronal 
differentiation (Dingemans et al. 2007; Herbstman et al. 2010), and on the migration of 
neuronal precursors during development (Schreiber et al. 2010). Strict legal requirements on 
flammability properties are only one issue impeding the delicate choice for an alternative to 
brominated flame retardants. Beyond that, toxicological information plays an important role 
for human safety. Unfortunately such information is rather limited. As a promising approach 
for the substitution of polybrominated compounds, phosphorus flame retardants such as the 
inorganic red phosphorus or ammonium polyphosphate (Schartel et al. 2010), halogenated 
phosphorus flame retardants, and phosphonamidates and phosphoesters (Costa et al. 2007; 
van der Veen et al. 2012) are currently applied to meet regulatory flammability standards. 
Several of these replacements are additives and not covalently bound to their host material, 
thus allowing their diffusion out of the host material by volatilization, leaching, or by 
mechanical abrasion (Marklund et al. 2003). In case of the chlorinated phosphorus flame 
retardant tris(chloropropyl)phosphate (TCPP), that was intensively applied as alternative for 
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brominated additives, concentrations in the environment, but also in indoor ambient air and in 
household dust, even exceeded levels of polybrominated diphenyl ethers (PBDEs) (Staat et al. 
2005; Tollbäck et al. 2006; van der Veen et al. 2012; Martinez-Carballo et al. 2007). Recent 
observations indicated a carcinogenic potential of TCPP (Ni et al. 2007; WHO 1998), hence 
justifying concerns on whether the alternatives currently used actually represent a lower risk 
than the compounds they are supposed to replace (Behl et al. 2015). These safety concerns on 
the industrial application of phosphorus flame retardants deserve even more attention when it 
is considered that structurally related phosphodiester compounds, such as organophosphorus 
pesticides, were reported to adversely influence the development of the nervous system and 
are indeed also used as chemical warfare agents (Gonzalez-Alzaga et al. 2014; Munoz-
Quezada et al. 2013). 
One of the potential substituents, that represents the basis for the here introduced novel 
structures, is the halogen-free organophosphorus flame retardant 9,10-dihydro-9-oxa-10-
phosphaphenanthrene-10-oxide (DOPO) that displays excellent flame retardation properties, 
and exhibited an only low acute toxicity potential in the currently available studies (Waaijers 
et al. 2013a, 2013b). In order to improve its flame retardation potential, and to influence its 
biophysical parameters such as its melting point, which is requested by the industry for 
application in different plastic materials, novel phosphonamidate and phosphorester 
derivatives of DOPO have been described as alternatives (Gaan et al. 2009, 2014; Buczko et 
al. 2014; Neisius et al. 2014) but were so far not evaluated with respect to their toxicological 
potential. In the combustion process, these phosphonamidates primarily act in the vapor phase 
by the formation of phosphorus-containing low energy radical species (PO). These radical 
species interact with OH or H radicals (equation 1) that are formed during combustion, and 
therefore lead to a reduction in the release of heat, hereby favoring the extinguishing of the 
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flame. In a subsequent step, the reduced phosphorus compound interacts with a second H 
radical (or OH), allowing a recycling of the PO species (equation 2) 
(1)  PO + H    HPO 
(2)  2 HPO + 2 H + O2     2 PO  + 2 H2O 
The application of such novel DOPO-derived phosphorus flame retardants is currently 
precluded by limited information regarding their adverse effects on human development and 
health. In the present study, we assessed three novel bis-DOPO-derived flame retardants in 
direct comparison to their parental compound DOPO and to the polybrominated diphenyl 
ether PBDE-99 with respect to their cytotoxic potential, their skin sensitization and skin 
penetration properties, and their neurotoxic and neurodevelopmental properties by a battery of 
different in vitro test systems – pursuing the 3R concept. We relate the cytotoxicity profile to 
viability data in Daphnids and growth rates of algae. These toxicological investigations, 
together with a comparison of their flame retardation properties when applied as additives in 
polyurethane foams, indicated that 6,6’-(ethane-1,2-diylbis(azanediyl))bis(6H-
dibenzo[1,2]oxaphosphine 6-oxide (EDA-DOPO) combines both superior flame retardation 
features with a significantly lower cytotoxic potential and might therefore emerge as a new 
candidate for the substitution of currently applied flame retardants. 
 
Experimental procedures 
Synthesis of DOPO-derivatives 
9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide (DOPO) was purchased from 
Metadynea GmbH (Austria), all other chemicals were purchased from Sigma Aldrich 
(Switzerland) and were used without further purification. NMR spectra were collected at 
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ambient temperature using a Bruker Avance 400 NMR spectrometer. 1H and 13C{H} NMR 
spectra were referenced against the solvent (DMSO-d6). 31P{H} NMR spectra were 
referenced against external 85% H3PO4.  
Synthesis of EG-DOPO:  A four neck round bottom flask (1 l) connected to additional funnel, 
condenser, mechanical stirrer, thermometer and bubbler, was charged with DOPO (100 g, 
0.46 mol), Ethylene glycol (14.35 g, 0.23 mol), 1-methylimidazole (39.88 g, 0.48 mol) and 
CH3CN (300 ml). The reaction vessel was immersed in an ice bath and CCl4 (72.93 g, 0.47 
mol) was added under N2 at a rate such that the reaction temperature did not exceed 10 °C. 
After complete addition, the reaction temperature was allowed to warm up to ambient 
temperature, and the reaction was refluxed for 3 h. The reaction was then cooled down to 40 
°C, and poured into DCM (300 ml). The organic was then washed with water (3 x 500 ml) 
and brine (1 x 500 ml) and dried over Na2SO4. The organic solution was filtered and the 
volatiles were removed under reduced pressure. The solid was then dissolved in minimum 
amount of Ethanol. Water (4 l) was then added slowly with vigorous stirring. The mixture was 
then stirred overnight. The aqueous solution was decanted and the washing step was repeated 
until the product becomes hard solid. The product was collected and extra dried under vacuum 
at 60 °C. Yield: 72.5 g, (64 %), m.p. 110.4 °C and 147.6 °C. Set of diastereomers: 1H NMR 
(DMSO-d6, 400.18 MHz) δ (ppm): 8.23-8.20 (m, 2H), 8.15 (dd, 2H, J = 8.0 Hz, J = 1.5 Hz), 
7.84-7.80 (m, 2H), 7.75-7.68 (m, 2H), 7.54 (ds, 2H, J = 3.7 Hz, J = 0.8 Hz), 7.45-7.40 (m, 
2H), 7.34-7.30 (m, 2H), 7.20 (dd, 1H, J = 2.7 Hz, J = 1.2 Hz), 7.18 (dd, 1H, J= 2.7 Hz, J= 1.2 
Hz), 4.28-4.08 (m, 4H). 13C NMR (DMSO-d6, 100.62 MHz) δ (ppm): 149.05 (d, J = 7.7 Hz), 
136.19 (d, J = 7.2 Hz), 134.02 (d, J = 2.5 Hz), 130.88, 129.73 (d, J = 9.3 Hz), 128.67 (d, J = 
15.2 Hz), 125.82, 125.07, 124.62 (d, J = 11.8 Hz), 121.80 (d, J = 11.8 Hz),  121.36 (d, J = 
179.3 Hz), 119.84 (d, J = 6.6 Hz), 65.29 (dt, J = 5.9 Hz, J = 1.9 Hz). 31P NMR (DMSO-d6, 
161.99 MHz) δ (ppm) 9.91 
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Synthesis of EDA-DOPO: A four neck round bottom flask (1 l) connected to additional 
funnel, condenser, mechanical stirrer, thermometer and bubbler, was charged with DOPO (75 
g, 0.35 mol), Ethylenediamine (8.34 g, 0.14 mol), Triethylamine (38.62 g, 0.38 mol) and 
CHCl3 (400 ml). The reaction vessel was immersed in an ice bath, and CCl4 (58.70 g, 0.38 
mol) was added under N2 at a rate such that the reaction temperature did not exceed 10 °C. 
After complete addition, the reaction temperature was allowed to warm up to ambient 
temperature and stirred overnight. The white product was then collected by filtration and was 
washed with CHCl3, Ethanol and then water, respectively. The product was collected and 
extra dried under vacuum at 60 °C. Yield: 60.1 g, (88.7%), m.p. 255-257 °C. Set of 
diastereomers: 1H NMR (400.18 MHz, DMSO-d6) δ (ppm): 8.17- 8.11 (m, 4H), 7.80-7.76 (m, 
1H), 7.75-7.70 (m, 3 H), 7.56-7.49 (m, 2H), 7.43-7.38 (m,2H), 7.30-7.25 (m, 2H), 7.18-7.13 
(m, 2H), 5.76-5.71 (m, 2H), 2.89-2.81 (m, 4H). 13C NMR (100.62 MHz, DMSO-d6) δ (ppm): 
149.41 (d, J = 7.2 Hz), 135.97 (d, J = 6.8 Hz), 132.74,  130.37, 129.41 (d, J = 9.6 Hz), 128.34 
( d, J = 14.3 Hz), 125.42 (d, J = 0.8 Hz), 125.24 (d, J = 161.7 Hz), 124.27, 124.08 (d, J = 10.7 
Hz), 121.92 (d, J = 11.5 Hz), 120.05 (d, J = 5.8 Hz), 41.75 (d, J = 5.7 Hz).  31P NMR (161.99 
MHz, DMSO-d6) δ (ppm): 15.29, 15.25. 
Synthesis of ETA-DOPO: A four neck round bottom flask (1 l) connected to additional funnel, 
condenser, mechanical stirrer, thermometer and bubbler, was charged with DOPO (150 g, 
0.63 mol) , Ethanolamine (21.2 g, 0.34 mol), Triethylamine (77.23 g, 0.76 mol) and CHCl3 
(400 ml). The reaction vessel was immersed in an ice bath, and CCl4 (117.40 g, 0.76 mol) was 
added under N2 at a rate such that the reaction temperature did not exceed 10 °C. After 
complete addition, the reaction temperature was allowed to warm up to ambient temperature 
and stirred overnight. The organic solvent was then concentrated under reduced pressure and 
the white precipitate was collected by filtration. The filtrate was then completely evaporated 
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under reduced pressure. The white product was then combined and washed with ethanol and 
water successively. The product was collected and extra dried under vacuum at 60 °C. Yield: 
135.8 g, (80 %), m.p. 177-178 °C. Set of diastereomers: 1H NMR (400.18 MHz, DMSO-d6) δ 
(ppm): 8.25 (t, J = 7.2 Hz, J = 1H), 8.21-8.12 (m, 3H), 7.93-7.83 (m, 2H), 7.74-7.69 (m, 1H), 
7.68-7.59 (m, 2H), 7.48-7.39 (m, 3H), 7.34 (dt, J = 0.8 Hz, J = 7.6 Hz, 1H), 7.31-7.26 (m, 
2H), 7.15 (ddd, J = 1.0 Hz, J = 8.1 Hz, J = 14.0 Hz, 1H), 5.87-5.80 (m, 1H), 4.13-3.94 (m, 
2H), 3.11-2.91 (m, 2H). 13C NMR (100.62 MHz, DMSO-d6) δ (ppm): 149.35-149.15 (8 
resonances), 136.29-135.87 (8 resonances), 134.03 (d, J = 2.4 Hz), 132.75 (d, J = 2.2 Hz), 
130.92 (d, J = 0.8 Hz), 130.40), 129.93 (dd, J = 2.0 Hz, J = 9.3 Hz), 129.43 (d, J = 9.6 Hz), 
128.75 (dd, J = 1.1 Hz, J = 15.1 Hz), 128.27 (dd, J = 3.2 Hz, J = 14.3 Hz), 125.90-125.87 (3 
resonances), 125.41, 125.29 (dd, J = 2 Hz, J = 163.0 Hz), 125.09, 124.66 (d, J =11.7 Hz), 
124.30, 124.06 (dd, J = 1.3 Hz, J = 11.1 Hz),  122.02-121.84 (8 resonances), 121.57 (d, 178.8 
Hz), 120.14-120.05 (4 resonances), 119.92-119.83 (4 resonances), 66.19-66.03 (m), 40.43 (d, 
J = 7.0 Hz). 31P NMR (161.99 MHz, DMSO-d6) δ (ppm): 14.59, 14.57, 9.83, 9.79 (Buczko et 
al. 2014; Salmeia et al. 2015) 
 
UL94-HB (horizontal burning) fire tests 
The UL-94 (ATSM D 4986 or ISO 9772) flammability standard test was applied to classify 
the flame retardation potential of the organophosphorus compounds embedded as additives in 
polyurethane (PU). The PU foams were cut to the dimension of 150 mm x 50 mm x 13 mm 
(length x width x thickness). Test specimens were marked at 25 mm, 60 mm, and 125 mm. 
The test specimens were placed on an iron grid in a horizontal position with a cotton indicator 
beneath. A 38 mm flame was then applied to the end of the specimen for 60 s and then 
removed. The time required for burning of a 100 mm long segment was recorded. The flame 
retardation potential of the different compounds tested was classified according to the UL-94 
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horizontal flammability criteria. Classification: HF 1: burning time after removal of external 
flame:  2 s in 80 % of the test specimens and  10 s in the remaining 20 % of test specimens. 
Afterglow time for each individual specimen:  30 s. Damaged length for each specimen  60 
mm. No ignition of cotton indicator by burning drops or particles. HF 2: same conditions as 
HF 1 with the exception that cotton is ignited by buring drops or particles. HBF: burning rate 
 40 mm/min over a distance of 100 mm or burning length  125 mm. UL 94 horizontal 
ratings classifications HF1 > HF2 > HBF > no ratings.  
 
Toxicity assessment in human alveolar epithelial cells 
The human alveolar epithelial cell line A549 (ATCC: CCL-185) was grown in Roswell Park 
Memorial Institute (RPMI-1640) medium (Sigma-Aldrich) supplemented with 10% FCS 
(Lonza), 0.2 mg/ml L-glutamine (Gibco), 50 µg/ml penicillin (Gibco), 50 µg/ml streptomycin 
(Gibco), and 100 µg/ml neomycin (Gibco) in humidified atmosphere at 37°C and 5% CO2 
(thereafter referred to as complete cell culture medium and standard growth conditions, 
respectively). Cells were subcultured at approximately 80-90% confluency using 0.5% 
Trypsin-EDTA (Sigma-Aldrich). For viability assessment, 1.5 x 104 cells were seeded in 200 
µl complete cell culture medium per well of a 96-well plate and grown over night under 
standard growth conditions. Thereafter, cells were treated for 48 h with 200 µl standard 
growth medium per well containing increasing concentrations of the respective flame 
retardants or CdSO4 as the positive control. The CellTiter96® AQueous One Solution 
(Promega) containing MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy phenyl)-2-(4-
sulfophenyl)-2H) as the water soluble tetrazolium compound was used according to the 
manufacturer’s protocol and detected at 490nm. 
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Toxicity assessment in human macrophages 
The human monocytic cell line THP-1 (ATCC: TIB-202) was grown as a single cell 
suspension in complete cell culture medium at standard growth conditions. Subculturing was 
performed by replacement of medium at cell concentrations starting from 8 x 105 cells/ml. 
Cell concentrations were not allowed to exceed 106 cells/ml. To differentiate THP-1 
monocytes into macrophages, cells were grown in the presence of 200 nM phorbol 12-
myristate 13-acetate (PMA; Sigma-Aldrich) for 72 h. For viability assessment, 8 x 104 cells 
were seeded in 200 µl complete cell culture medium containing 200 nM PMA per well of a 
96-well plate and differentiated for 72 h under standard growth conditions. Thereafter, 
medium was removed, cells were washed twice with pre-warmed PBS and increasing 
concentrations of flame retardants or CdSO4 were added in 200 µl complete cell culture 
medium per well for 48 h. The CellTiter96® AQueous One Solution (Promega) containing 
MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy phenyl)-2-(4-sulfophenyl)-2H) as 
the water soluble tetrazolium compound was used according to the manufacturer’s protocol 
and absorption was detected at 490 nm. 
 
3D epidermal in vitro model 
Human primary keratinocytes (PR3D-HPEK-50, CELLnTEC, Bern, Switzerland) were grown 
in flasks in proliferation medium (CNT-PR, CELLnTEC) until sub-confluency was reached. 
The cells were then seeded into transwell inserts containing polycarbonate membranes with a 
pore size of 0.4 µm at a density of 3.3*105 cells/cm2 and grown for 3 days in CNT-PR until 
confluency was reached. Differentiation was initiated by the addition of 3D barrier medium 
(CNT-PR-3D, CELLnTEC) for 18 h to allow development of cell-to-cell adhesion structures. 
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3D growth and differentiation was induced by complete removal of medium from the upper 
transwell compartment and the replacement of CNT-PR-3D differentiation medium in the 
lower compartment. Cells were allowed to differentiate for 11 days with 3 medium changes 
per week in the lower compartment and direct cell-to-air contact on the top. Flame retardants 
were suspended at a concentration of 200 mM in PBS (phosphate buffered saline) containing 
5 % DMSO (dimethyl sulfoxide) and 100 µl were applied on top of the epithelial barrier 
model according to the OECD guidelines for chemicals testing on Reconstructed Human 
Epidermis “In vitro skin irritation tests”. 5 % SDS (sodium dodecyl sulfate) was used as 
cytotoxic chemical (positive control) and 5 % DMSO in PBS as negative control. The 
epidermal models were treated for 15 min at 37 °C and washed 3 times with PBS, before they 
were further cultivated for 48 h in fresh medium. Cell viability in the epidermal models was 
measured by resazurin reduction to resorufin (PrestoBlue® Assay). Cell viability values 
(fluorescence signals) were normalized to epidermal models thickness. Tissues were later 
washed with PBS and fixed in 10 % formalin at room temperature for 2.5 h. The membranes 
carrying the 3D epidermis were removed from the transwell plates and washed using PBS. 
The 3D epidermis was dehydrated with the consecutive addition of: 70 % EtOH for 1 h; 96 % 
EtOH for 1 h; 96 % EtOH for 1 h, 100 % EtOH for 1 h, 100 % EtOH for 1 h; extraction 
solvent 1 h; extraction solvent 1.5 h, paraffin 1.5 h, paraffin 1.5 h. Paraffin blocks were cut 
with a microtome (Zeiss, Hyrax M40) into 5 µm slices that were heated at 55°C for 1 h. 
Samples were re-hydrated in xylol and decreasing ethanol concentrations (2 min) and placed 
in water for 2 min, before they were stained with hematoxylin for 15 s. After this staining 
step, the slides were `blued` under rinsing tap water (5 min) and subsequently applied to 75 % 
EtOH and 96 % EtOH for 2 min in order to stain them with alcoholic eosin (4 min). Finally 
the slides were washed using 96 % ethanol and dehydrated with abs. EtOH and xylol. 
Samples were mounted with DPX mounting medium (Sigma-Aldrich) and analyzed by 
microscopy (Olympus IX 81, Programm Cell Sense). 
12 
 
Skin sensitization assay 
Generation of the stable cell line KeratinoSens was previously described in detail (Emter et al.  
2010). Briefly, HaCaT cells were stably transfected with a luciferase reporter gene under the 
control of a copy of the antioxidant response element (ARE) of the human aldo-keto-
reductase family 1, member C2 (AKR1C2) gene. KeratinoSens cells were maintained in 
DMEM containing glutamax (Gibco/Invitrogen), 9 % FCS and 0.5 mg/ml G418. For 
experiments, the cells were seeded onto 96-well plates at a density of 10.000 cells per well in 
125 µl medium without G418. After 24 h, medium was replaced by 200 µl DMEM containing 
1% FCS and the compounds tested. After a 2 day incubation period at 37°C, 5% CO2, the 
cells were washed once with PBS and a Resazurin reduction assay (PrestoBlue®) was carried 
out in order to compare the viability of the differently treated cells. The fluorescence intensity 
was measured at 530 nmex and 590 nmem. After another washing step with PBS cell lysis was 
performed using 20 µl/well passive lysis buffer (Promega, Duebendorf, CH) for 20 min at RT. 
Luciferase activity was measured by applying 50 µl luciferase substrate automatically to each 
well and detecting thereby a luminescence signal. 
 
Quantitative detection of flame retardants in porcine skin by confocal Raman spectroscopy 
The vertical distribution of topically applied DOPO derivatives and reference compounds was 
investigated on segments of porcine ears from freshly slaughtered animals. The skin was 
separated from the cartilage, depilated, and placed into Franz type diffusion cells (xxx cm2). 
The acceptor solution was PBS buffer containing XXX % of IGEPAL® CA-630 (Sigma 
Aldrich). Test compounds were dispersed at a concentration of 400 µM (2 % in case of 
caffeine) in PBS buffer containing XXX % of IGEPAL® CA-630 300 µl of this mixture 
including a blank solution were topically applied to the porcine skin and allowed to penetrate 
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for 60 min. Then, the skin was removed from the Franz cells, gently washed, and placed to the 
optical window of the inverse confocal Raman microscope (Model 3510 SCA, River 
Diagnostics).  The Raman microscope is equipped with a 60x oil-immersion objective. The 
785 nm excitation laser was used to acquire spectra in the fingerprint region (400 – 1800 cm-1, 
integration time 5 s) starting from the skin’s surface down to a depth of 60 µm (step size of 2 
µm). The acquisition was repeated at five positions at least. Averaged concentration profiles 
of flame retardants and reference compounds were extracted by fitting (unrestricted classical 
least squares, third order polynomial baseline) the Raman spectra with reference spectra of 
keratin (as representative of all proteins), water, ceramide 3 and cholesterol (as 
representatives of all lipids), NMF (fixed composition of natural moisturizing factor), lactate, 
urea, and the solid test compounds using Skin Tools software. Concentrations of test 
substances are given as molar fraction relative to keratin rather than correcting for the Raman 
signal attenuation by mathematical models (Franzen et al. 2013). Response factors of the test 
compounds had been determined against BSA solutions assuming similar Raman cross-
sections for keratin and BSA as described in the literature (Caspers et al. 2001; Fleischli et al. 
2013). Since EDA-DOPO, ETA-DOPO, and EG-DOPO were only partially soluble in 
chloroform, their spectra were calibrated against DOPO assuming the same Raman cross 
section for the biphenyl group. Due to the nature of the unrestricted fit, negative fitting 
coefficients can be obtained and the values must be compared to those of the blank. The 
fitting coefficients of the blank treated skin were also used to estimate the level of detection. 
The depth resolution of the confocal microscope was determined to be 8 µm at FWHM 
leaving an uncertainty of approx. 4 µm in differentiating between truly permeated compounds 
and compounds sitting at the surface of the skin. 
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Toxicity assessment of central nervous system neurons 
LUHMES cells are conditionally immortalized human fetal ventral mesencephalic neuronal 
precursor cells that were obtained by clonal selection. Differentiated LUHMES cells show a 
clear dopaminergic phenotype which was described in detail previously (Schildknecht et al. 
2009; Scholz et al. 2011). Cells were propagated in Advanced DMEM/F12 (Gibco/Invitrogen, 
Darmstadt, Germany), 1x N2 supplement (Invitrogen), 2 mM L-glutamine (Gibco), and 40 
ng/ml recombinant bFGF (R+D Systems; Minneapolis, MN). The differentiation process was 
initiated by addition of differentiation medium consisting of advanced DMEM/F12, 1x N2 
supplement, 2 mM L-glutamine, 1 mM dibutyryl-cAMP (Sigma), 1 µg/ml tetracycline 
(Sigma), and 2 ng/ml recombinant human GDNF (R+D Systems). After 2 days, cells were 
trypsinized and collected in Advanced DMEM/F12 medium. Cells were seeded onto 24-well 
plates at a density of 160.000 cells/cm2. The differentiation process was continued for 
additional 4 days. Fully differentiated LUHMES were treated with the various flame 
retardants for 48 h from day 6-8 of differentiation. For visualization of morphology, cells 
were fixed with 4% paraformaldehyde for 20 min at room temperature, permeabilized with 
0.2 % Triton X-100, washed with PBS, blocked with 1 % BSA (Calbiochem, San Diego, CA) 
in PBS for 1 h and stained with a polyclonal anti--III-tubulin antibody (Sigma) in 1% 
BSA/PBS at 4°C over night. After washing, the secondary antibody (anti-mouse-IgG, Alexa 
488, Molecular Probes; 1:1000) in 1% BSA/PBS was added for 1 h, nuclei were stained by 
Hoechst dye H-33342 (1 µg/ml) for 20 min. For visualization, an Olympus IX 81 microscope 
(Hamburg, Germany) equipped with a F-view CCD camera was used. For quantitative 
evaluation of the neurite area, the -III-tubulin-stained cells were analyzed using an 
automated microplate-reading microscope (Array-Scan II HCS Reader, Cellomics, 
Pittsburgh, PA) equipped with a Hamamatsu ORCA-ER camera (resolution 1024 x 1024; run 
at 2 x 2 binning). Nuclei were identified as objects according to their intensity, size, area and 
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shape. A virtual area corresponding to the cell soma was defined around each nucleus. The 
total -III-tubulin pixel area per field minus the soma areas in that field was defined as neurite 
mass.  
 
Toxicity assessment of peripheral nervous system neurons 
The human pluripotent stem cell (hPSC) line H9 (WA09 line) was obtained from WiCell 
(Madison, WI, USA). Import of cells and experiments were authorized under license # 170-
79-1-4-27 (Robert Koch Institute, Berlin, Germany). Cells were cultured according to 
standard protocols (Thomson et al. 1998) and differentiated into dorsal root ganglia-like cells 
as described earlier (Chambers et al. 2012), with slight modifications. Briefly, neural 
differentiation was promoted by adding neural differentiation medium and the combination of 
6 small molecule pathway inhibitors (noggin (35 ng/ml; R&D Systems Minneapolis, USA) 
dorsomorphin (600 nM; Tocris Bioscience, Bristol, UK), SB-431642 (10 μM; Tocris 
Bioscience, Bristol, UK), CHIR99021 (1.5 µM; Axon Medchem, Vienna, USA), SU5402 (1.5 
µM; Tocris Bioscience, Bristol, UK) and DAPT (5 µM; Merck, Darmstadt, Germany). On 
day 8 of differentiation (DoD 8) cells were cryopreserved. For each single experiment, cells 
were thawed in neural differentiation medium supplemented with CHIR99021 (1.5 µM), 
SU5402 (1.5 µM) and DAPT (5 µM). For the peripheral neurotoxicity test (PeriTox-test), test 
chemicals were serially diluted in differentiation medium containing BDNF, GDNF and NGF 
(25 ng/ml; R&D Systems Minneapolis, USA) and added to the cells at day 3 after thawing. 
After 48 h, neurite area and viability were assessed as described earlier (Krug et al. 2013). 
Briefly, cells were loaded with 1 µM calcein-AM and 1 µg/ml H-33342 for 1 h at 37°C. For 
image acquisition, an Array-Scan VTI HCS (high contenting imaging microscope) 
(Cellomics, Waltham, MA USA) was used. In an automated procedure, all H-33342+/calcein+ 
cells were analyzed as viable cells.  
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Neural crest cell (NCC) migration assay 
Human embryogenic stem cells (H9 hESC line) (Wisconsin International Stem Cell Bank, 
Madison, WI, USA) were plated on a confluent layer of Mitomycin C-treated murine bone 
marrow-derived stromal MS5 cells in KSR medium (DMEM, 15% serum replacement, 1x 
GlutaMax, non-essential amino acids, β-mercapto ethanol). After 12 days, medium was 
changed to N2 medium (DMEM/F12 containing glucose, insulin, apo-transferrin, putrescine, 
selenite, progesterone, sonic hedgehog, fibroblast growth factor 8, brain derived neurotrophic 
factor, ascorbic acid). After 21 days, rosettes were picked and plated onto poly-L-
ornithine/laminin/fibronectin coated plates in N2 medium. After 7 days, cells were FACS 
sorted for positive expression of p75 and HNK-1 and expanded for 28 days in N2 medium 
supplemented with EGF (20 ng/ml) and FGF2 (20 ng/ml). For the following 28 days, cells 
were passaged 4-5 times for expansion, detached by accutase (PAA, Pasching, Austria) and 
cryopreserved in 90% FCS, 10% DMSO. For the analysis of neural crest cell migration, 
silicone stoppers (Platypus Technologies, Madison, WI, USA) were inserted in a 96 well plate 
coated with poly-L-ornithine/laminin/fibronectin. Freshly thawed NCCs were seeded at a 
density of 100.000 cells/cm2 in N2 medium containing EGF and FGF2 and allowed to attach 
for one day. Stoppers were removed and the cells were allowed to migrate into the center of 
the well. Compounds tested in this study were applied for 24 h. For single cell detection, cells 
were stained with H-33342 (1 µg/ml) and calcein-AM (0.5 µM). Viability was assessed by 
counting the number of H-33342 and calcein double-positive cells outside the migration zone, 
migration was detected by acquisition of the number of H-33342 and calcein-double positive 
cells with the migration area.   
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Statistics  
Values are expressed as the mean  SD. If not otherwise indicated, experiments were 
performed at least three times with three technical replicates in each experiment. Data were 
analyzed by one-way ANOVA or Student´s t-test as appropriate, differences were determined 
by Bonferroni´s post hoc test (Prism or Origin software). If not otherwise indicated, means 
were considered as statistically significant at p < 0.05. 
 
Results 
Synthesis and flame retardation properties of DOPO-derivatives 
During combustion of the host material, the organophosphorus flame retardant DOPO 
primarily acts in the gas phase and forms low energy PO radicals that can interact with H or 
OH radicals and thus lower the amount of released energy (Neisius et al. 2014). In order to 
modulate the biophysical properties of DOPO for an optimization of its use in polyurethane 
foams and to further improve its flame retardation potential, three novel bis-DOPO 
derivatives comprising an alkyl spacer linked via N-and O-atoms to the central phosphate 
moieties (Fig. 1a) were synthesized as recently described (Qiang et al. 2011; Gaan et al. 
2013). The flame retardation potential was evaluated by subjecting the new compounds, 
embedded into polyurethane, to the UL-94 horizontal burning fire test (Fig. 1b). When added 
to soft polyurethane foams, the three novel bridged DOPO-derivatives achieved higher flame 
retardation ratings compared with the two chlorophosphates TCCP and TCEP that served as 
widely applied reference compounds (Fig. 1b). The flame retardation potential of the DOPO-
derivatives was significantly higher compared with their parental compound DOPO. (UL 94 
classification: HF 1 > HF 2 > HBF) (Fig. 1b). The fire burning test clearly indicated that the 
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novel bis-DOPO derivatives display superior flame retardation properties compared with the 
compounds they are supposed to replace. These features prone them as potential new 
candidates for use in several plastic materials of everyday common household goods, posing 
however also the question on their adverse influence on human health.  
 
Acute toxicity assessment of DOPO-derivatives 
Based on their superior flame retardation potential combined with their beneficial properties 
for application in polyurethane foams, the three DOPO-derivatives were tested in a series of 
different in vitro models in order to obtain initial information on their potential harmful 
properties. To allow a comparison with published toxicological data of other flame retardants, 
DOPO but also PBDE-99, as representative for the class of polybrominated diethyl ethers, 
were tested in parallel in all assays applied in this work. Inhalation is considered as one of the 
dominating routes of exposure for flame retardants. Therefore, we first applied the human 
lung epithelial cell line A549 as well as human macrophages, differentiated from the 
monocyte cell line THP-1, and exposed them to the respective flame retardants for a period of 
2 days. While DOPO, EDA-DOPO, and PBDE-99 exhibited no signs of cell damage at 
concentrations up to 400 µM, acute toxicity in both cell models was detected with ETA-
DOPO and EG-DOPO at concentrations > 20 µM (Fig. 2). These findings confirm 
observations in the literature, describing the absence of cell damage by PBDE-99 in A549 
cells in the same concentration range (Kim et al. 2014). Another report assessed DOPO 
toxicity in PC12 and B35 neuroblastoma cell models and also observed no damage in a 
comparable concentration range as applied herein, further confirming the low cytotoxic 
potential of DOPO (Hendriks et al. 2014). 
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For cell types primarily involved in the inflammatory response, such as macrophages or 
astrocytes, previous reports indicated an inflammatory activation in response to their exposure 
to flame retardants (Koike et al. 2014). We hence tested the release of the proinflammatory 
cytokines TNF- and IL-8 in differentiated THP-1 macrophages and could not observe any 
significant release (Suppl. Fig. 1a + b). It was recently reported that PBDE-47 and PBDE-209 
would induce oxidative stress and thereby contribute to DNA damage (Pellacani et al. 2012). 
In A549 cells, no significant increase in reactive oxygen species could be observed (Suppl. 
Fig. 1c), nor were we able to detect DNA strand breaks in A549 or LUHMES cells exposed to 
the flame retardants tested in this work (Suppl. Fig. 2 + 3). As alternative readout for the 
assessment of a potential inflammatory activation evoked by the flame retardants, the 
translocation of cytosolic subunits of the NF-B complex into the nucleus was investigated in 
astrocytes and, similar to the situation in macrophages, no influence could be detected (Suppl. 
Fig. 4).  
For further comparison with published DOPO toxicity data, the standardized acute daphnia 
immobilization (OECD guideline 202) test was employed. An EC50 of roughly 1.5 mM was 
recently reported for DOPO (Waaijers et al. 2013). In our testing of EDA-DOPO, ETA-
DOPO, or EG-DOPO, even the highest concentrations applied (water soluble fraction of a 
1000 mg/l ≈ 2mM solution) resulted only in minimal immobilization of 5-10 % of the 
daphnids (Suppl. Fig. 5). In an alternative OECD-approved assay (OECD guideline 201), 
freshwater microalgae were exposed to the flame retardants. At the highest concentrations 
(water soluble fraction of a 1000 mg/l ≈ 2mM solution), EG-DOPO displayed a declined 
algae growth while EDA-DOPO and ETA-DOPO exhibited no effect (Suppl. Fig. 6).  
In conclusion, our observations underline a low acute toxic potential of DOPO and its 
derivatives in non-neuronal cells and in lower freshwater organisms. The application of 
DOPO and PBDE-99 allowed some overlap with previously published data and confirmed 
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them. These observations allow a comparison of our data on the novel DOPO-derivatives with 
other reports and enable an integration of the herein presented toxicological data into a 
network of data in the literature. 
 
Interaction of DOPO-derivatives with epidermal barriers. 
Dermal uptake of flame retardants present in ambient air, household dust, or by direct contact 
with plastic-containing materials, emerged as a major uptake route besides ingestion and 
inhalation. To assess their influence on the integrity of the epidermis, a 3D human in vitro 
epidermal model was topically exposed to high concentrations (10 mM, 50 mM, 200 mM) of 
the respective flame retardant for 48 h. Even at the highest concentrations applied onto the 
Stratum corneum, all flame retardants tested displayed no detectable influence on the 
architecture of the epidermis (Fig. 3a). As positive control, SDS (5 %) was added to the model 
and resulted in a complete disintegration of the Stratum corneum and substantial cell death in 
the Stratum spinosum. Viability of the epidermis was detected by the PrestoBlue® assay and 
indicated no significant changes when exposed to the flame retardants (not shown). The 
observed absence of significant epidermal damage could either be the result of a negligible 
penetration of the compounds into the epidermis, or it could be the consequence of a higher 
resistance of epidermal cells compared with other cell types. To address the aspect of 
penetration into a complex skin structure, the different flame retardants were topically applied 
on segments of porcine ears from freshly slaughtered animals. Uptake was detected in a non-
invasive manner by application of confocal Raman spectroscopy (Fig. 3b). Caffeine was used 
as positive control, indicating a significant penetration of ETA-DOPO and a moderate uptake 
of PBDE-99, while all other compounds displayed no detectable penetration into the skin 
within the investigated time period of 1 h.  
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In order to analyze the irradiative potential of the various flame retardants when in direct 
contact with epidermal cells, a keratinocyte-based cell model optimized to detect electrophilic 
skin sensitizing compounds was utilized in the next step. With this model, covalent 
modifications of active site cysteine residues in Keap1 by electrophiles lead to its dissociation 
from Nrf2 that subsequently accumulates in the nucleus to activate the expression of genes 
with an antioxidant response element (ARE) in their promoter (Emter et al. 2010). Treatment 
of the reporter construct-carrying keratinocytes with the various flame retardants revealed an 
increase in ARE-dependent luciferase expression by ETA-DOPO and EG-DOPO that was 
however inversely correlated with a decline in cell viability. Under the experimental 
conditions employed in Fig. 3c, the rise in luciferase signal hence can not be attributed to a 
specific innate response of the cells, but must rather be interpreted as the consequence of cell 
death-associated processes. Comparable effects were also observed with higher 
concentrations (>10 µM) of the positive control benzylidine acetone. PBDE-99 however lead 
to a concentration-dependent moderate increase in ARE-dependent luciferase expression in 
the absence of significant cell death, thus indicating a skin sensitization potential of PBDE’s. 
DOPO and EDA-DOPO exhibited neither an induction of luciferase activity nor an adverse 
effect on cell viability (Fig. 3c) in agreement with the observations of Fig. 2 made with 
human lung cells and macrophages. Taken together, these findings/results confirmed the 
cytotoxic potential of ETA-DOPO and EG-DOPO when added to 2D cell models.  
Based on the assays applied herein, a direct adverse influence of the flame retardants on 
epidermal integrity appears to play no significant role. There are also no reports indicating a 
direct degenerative influence of flame retardants present in household dust on human skin. 
More importantly, however, is the fact that some of the compounds have the potential to 
penetrate the Stratum corneum and hence can enter the human body. Our observations on the 
penetration of DOPO-derivatives was limited to only 1 h. Whereas uptake of ETA-DOPO and 
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PBDE-99 was apparent even after this short incubation period, it can not be excluded that 
under conditions of chronic interaction, also DOPO, EDA-DOPO, and EG-DOPO can 
penetrate the skin at quantitative amounts and hence enter the human body.  
 
Cytotoxicity of flame retardants in central nervous system neurons 
Previous studies on the toxicity of halogenated flame retardants indeed identified a wide 
spectrum of different cell types and organs affected, but they explicitly highlighted the 
adverse effects on neuronal integrity and on neurodevelopmental processes (Hendriks et al. 
2014). For investigations on the influence of the DOPO derivatives on central nervous system 
neurons, we applied human LUHMES cells that can be differentiated into mature post-mitotic 
neurons within 6 days (Schildknecht et al. 2009; Scholz et al. 2011). Fully differentiated 
LUHMES (day 6) were treated with varying concentrations of the different flame retardants 
(Fig. 4a) for a period of 2 days (day 6-8) (Fig. 4b). For visualization of cell morphology, cells 
were fixed and stained with an anti-β-III-tubulin antibody. In our previous studies with the 
LUHMES cells, we observed that neurite architecture serves as a far more sensitive marker 
for neuronal integrity than classical cell viability assays (Krug et al. 2013; Schildknecht et al. 
2013). For the quantitative assessment of total neurite mass, an automated microscope system 
with an analysis algorithm allowing the detection of total neurite mass was applied (Fig. 4c).  
In addition to that, cell viability was detected by following the reduction of resazurin and by 
the lactate dehydrogenase (LDH) release assay as well as by the detection of intracellular 
levels of ATP and reduced glutathione (GSH) (Supp. Fig. 7). In summary, all assays indicated 
a degeneration of neurites evoked by ETA-DOPO, EG-DOPO, and PBDE-99 at 
concentrations > 10 µM, while DOPO and EDA-DOPO exhibited no influence at 
concentrations up to 100 µM. These results were obtained with fully differentiated neurons. 
To investigate the influence of the flame retardants on neurite outgrowth when exposed 
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during the differentiation process, LUHMES were treated from day 0 to day 2 of their 
differentiation (Suppl. Fig. 8 and 9). Qualitatively, the same observations as with fully 
differentiated cells were made with the exception that EDA-DOPO also revealed a moderate, 
but significant influence on total neurite area. This effect was however not reflected by cell 
viability markers, respectively by the intracellular levels of ATP and GSH (Suppl. Fig. 8 and 
9). In order to introduce an alternative assay to investigate more subtle changes in neurite 
integrity, we investigated the migration of mitochondria in neurites of differentiated 
LUHMES (Suppl. Fig. 10). Treatment of the cells with the parkinsonian toxin MPP+, applied 
herein as a positive control, resulted in a significant decline in the velocity of mitochondrial 
migration in neurites, while all flame retardants under conditions where neurite integrity was 
not affected (25 µM, 12 h), exhibited no significant influence on mitochondrial migration 
(Suppl. Fig. 10). At high flame retardant concentrations, an influence on mitochondrial 
velocity was indeed observed with ETA-DOPO, EG-DOPO, and PBDE-99, however this 
effect was directly correlated with neurite degeneration and hence can not be considered as an 
independent toxicity parameter. 
In conclusion, analysis of neurite mass and integrity in both differentiating and fully 
differentiated LUHMES and its comparison with markers of general cell viability indicated 
that the flame retardants investigated evoke no neuro-specific degeneration. Instead, the 
observed impact on neurites could rather be considered as consequence of general cell 
degenerative processes.  
 
Toxicity of flame retardants in neurons of the peripheral nervous system 
Neurons of the central nervous system (CNS) are protected by the blood brain barrier in an 
organism. It can hence be speculated that neurons of the peripheral nervous system per se 
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represent a more vulnerable target either by their more direct exposure to environmental 
toxicants in vivo or by intrinsic features distinguishing them from CNS neurons. To analyze 
potential differences between central and peripheral neurons with respect to their response 
towards the flame retardants tested, we generated peripheral neurons from human stem cell-
derived neural precursors and treated these cells for a period of 48 h with the respective flame 
retardants during neuronal differentiation (Fig. 5a). Similar to the observations made with the 
CNS neurons, EG-DOPO and PBDE-99 significantly affected neurite integrity (Fig. 5b) and 
cell viability (Fig. 5c) while DOPO, EDA-DOPO and ETA-DOPO exhibited a moderate 
inhibitory influence on neurite outgrowth and general cell viability at concentrations > 50 µM. 
These observations indicate that no significant difference between central and peripheral 
neurons in vitro exists with respect to their degeneration in response to the flame retardants 
investigated. Although we did not explore/examine/analyze the underlying mechanisms 
leading to cell death, the parallel decline in neurite mass and in cell viability observed both in 
central- and in peripheral neurons, together with comparable responses of non-neuronal cells 
(Fig. 2 + 3), again suggest that DOPO and its derivatives evoke a cell type independent 
mechanism of cell damage.  
 
Influence of flame retardants on neural crest cell migration 
Adverse effects of a compound on the nervous system are not necessarily correlated with its 
direct toxicity or its influence on neuronal differentiation. Instead, only subtle changes in 
neural precursor migration during early development can have profound influence on the 
subsequent development of the nervous system. We therefore tested the flame retardants in a 
stem cell-derived human neural crest cell migration assay (Fig. 6). Cells were allowed to 
migrate into a cell-free area, migration as well as cell viability on the individual cell level 
were assessed as readouts. A quantitative analysis was conducted by an algorithm that in 
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addition detects cell numbers in order to exclude a contribution of cell proliferation to the 
migration events analyzed (Fig. 6a). While DOPO and EDA-DOPO displayed neither an 
inhibitory influence on cell migration nor on cell viability, ETA-DOPO and EG-DOPO both 
showed a concentration-dependent decline in cell migration and a decline in cell viability 
(Fig. 6b). PBDE-99 indicated a moderate, but significant inhibition of cell migration in the 
absence of impaired cell viability. Similar effects were observed with ETA-DOPO and EG-
DOPO in a relatively narrow concentration range of ca. 30-60 µM. In this range, migration 
was far more sensitive in its response towards these two flame retardants compared with the 
adverse influence on cell viability. In all neuronal assays, ETA-DOPO and EG-DOPO 
showed cytotoxic properties at significantly lower concentrations of flame retardants 
compared with DOPO and EDA-DOPO.  
 
Comparison and prioritization of organophosphorus flame retardants 
In the present work, different in vitro test systems for the assessment of potential adverse 
effects of the three novel DOPO-derivatives were implemented. To allow a better comparison 
between the individual compound’s safety profile, the IC50 values determined by these assays 
were plotted in a single graph (Fig. 7). Due to limitations in solubilization of the compounds 
at maximal residual DMSO levels of 0.1 %, maximal concentrations in two-dimensional cell 
culture experiments were limited to 400 µM. Within this concentration range, some assays 
displayed no reduction e.g. in viability and hence allowed no calculation of IC50 values. EDA-
DOPO, in all assays utilized, exhibited no harmful influence while the average IC50 values of 
ETA-DOPO and EG-DOPO were in the range of 20-100 µM in the models applied. The three 
novel DOPO-derivatives tested in the present work all exhibited a superior flame retardation 
potential compared with their parental compound DOPO. The present initial analysis 
employing a variety of different in vitro assays concordantly adverted a cell-damaging 
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potential of ETA-DOPO and EG-DOPO in a concentration range comparable to the toxicity 
potential of PBDE-99. EDA-DOPO displayed superior flame retardation features compared 
with its parental compound DOPO and at the same time evoked no harmful influence in all 
cell types and assays employed in this work.  
 
 
Discussion 
Acute toxicity of DOPO derivatives in cotext with current literature  data 
In the present work, novel halogen-free bis-DOPO compounds linked via alkyl spacers by N- 
and O-bonds were for the first time analyzed for their potential harmful influence by a set of 
cellular in vitro assays as well as their influence on Daphnid viability and algal growth. The 
three novel compounds were designed in order to possess an improved flame retardation 
potential, but also for a wider range of applications, based on their higher melting points and 
increased stability, that is a prerequisite for their use in the production process of plastic 
materials (Buczko et al. 2014; Gaan et al. 2013, 2015; Neisius et al. 2014; Salmeia et al. 2015; 
Qiang et al. 2011). In contrast to the current practice to investigate potential harmful 
properties of flame retardants after their introduction into the market, we applied here a series 
of different human in vitro screening assays to allow a fundamental toxicological 
classification before their production and application in industrial scales. Compared to the 
vast literature on the class of polybrominated diethyl ethers, covering aspects such as indoor 
and outdoor contamination levels, human uptake routes, accumulation in different organs and 
tissues, and their toxic effects in a variety of in vitro and in vivo test systems (Watkins et al. 
2011; Stapleton et al. 2014; Lyche et al. 2015; Liagkouridis et al. 2015), only limited data on 
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DOPO toxicity and no information on the harmful influence of bis-DOPO derivatives are so 
far available.  
In order to allow a direct comparison of the toxicological data presented in this study with 
published data on polybrominated diphenyls, the parental compound DOPO, as well as 
PBDE-99 as a representative example for the class of PBDE’s, were incorporated in all 
experiments of this work. At concentrations up to 400 µM, DOPO displayed no influence on 
all parameters investigated herein. These findings verify data from a previous study by 
Hendriks et al., in which rat adrenomedullary pheochromocytoma PC12 cells and rat 
neuroblastoma B35 cells, that were treated for 24 h with maximal concentrations of 100 µM 
DOPO, exhibited no signs of alterations in cell viability, generation of reactive oxygen 
species, or in intracellular Ca2+ levels (Hendriks et al. 2014). In a standardized Daphnia 
immobilization assay (OECD Guidelines for the Testing of Chemicals, Test No. 202), 
treatment of young daphnids with the water soluble fraction of a 1000 mg/l suspension (ca. 2 
mM), DOPO, added for 48 h was reported to show no significant influence on their viability 
(Waaijers et al. 2013). Our toxicological assessment of the three bis-DOPO compounds with 
the same standardized Daphnid model revealed no significant influence up to the highest 
concentrations applied (water soluble fraction of a 1000 mg/l suspension) (Suppl. Fig. 5). 
Based on this information, we applied DOPO as negative control reference compound in our 
experimental setups to allow a direct comparsion with currently available literature data and 
to enable an integration of the information generated in the present work into the existing 
network of toxicological data on the different classes of flame retardants. As positive control, 
we have chosen PBDE-99, as a representative example of the class of polybrominated 
diphenyls. Among the vast number of PBDE variants produced, five congeners (PBDE-47, 
PBDE-99, PBDE-100, PBDE-153, and PBDE-154) predominate in human tissues and 
account for more than 90 % of the PBDE’s detected in the human body (Stasinska et al. 
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2014). Literature data on PBDE-99, on the one hand, reported an absence of adverse effects in 
non-neuronal cells up to 100 µM that was further confirmed by our observations made with 
the A549 or THP-1 cells or with keratinocytes (Fig. 2 and 3). On the other hand, 
epidemiological investigations focusing on the correlation between PBDE exposure in early 
development with deficits in psychomotor  and IQ performance in later life, indicated a 
profound influence on the development and function of the neuronal system (Shy et al. 2011; 
Gump et al. 2014; Herbstman et al. 2010; Chevrier et al. 2010; Chao et al. 2011). Our 
observation on the selective influence of PBDE-99 on central and peripheral neuronal 
integrity was fundamentally supported by other in vitro observations in the literature 
indicating a pronounced selective toxicity in neuronal cells (Schreiber et al. 2010). These 
observations clearly indicate that the cell type selective toxicity of PBDE’s is adequately 
represented by the in vitro models employed in the present study. Combined with the 
observations made with DOPO that served as negative control in our work, the information on 
the toxicological response to PBDE-99 allows a direct comparison with the relatively large 
number of in vitro observations in the literature. Data on PBDEs in the literature allow some 
correlation between their toxicity in cell culture in vitro systems, their levels in different 
human organs and tissues and their adverse effects on psychomotor functions in humans. 
Under the assumption of comparable volatilization rates and bioaccumulation properties of 
PBDEs and bis-DOPO compounds, the data presented herein allow first speculations on the 
potential interference of bis-DOPO compounds with (neuro)-developmental processes in vivo. 
The ultimate approach to address these questions indeed presumes the inclusion of in vivo test 
models in the compilation of an adverse profile of these compounds. 
 
Comparison of in vitro and in vivo flame retardant burdens 
29 
 
Toxicological results obtained with in vitro models raise the question on actual in vivo 
concentrations in humans that are largely influenced by the biophysical properties of a given 
compound. The most comprehensive literature on indoor and outdoor contamination levels 
and on the compound’s organ- and tissue accumulation rates is currently available for PBDEs. 
A growing number of studies analyzing PBDE levels in different cohorts of various countries 
were published in recent years (Chao et al. 2007; Roze et al. 2009; Eskenazi et al. 2013). 
Exposure of infants was routinely observed as significantly higher compared with adults, 
largely as a result of the higher rate of oral, nasal, and dermal uptake, as well as of different 
toxicokinetic parameters compared with adults (Toms et al. 2009; Rose et al. 2010). PBDE-99 
was identified in office dust at concentrations of ca. 900 ng/g dust (Watkins et al. 2013). 
While uptake of house dust by adults was in the range of 20-50 mg/day, those of smaller 
children were found to reach values of 100-200 mg/day (Wilford et al.; U.S. EPA 2008). For 
children, these numbers imply a daily uptake of PBDE-99 in the range of 75 ng/day. Based on 
the lipophilicity and the ability to passage the placental barrier, breastfed infants are exposed 
to a ca. 300 fold higher oral dose of PBDE congeners per day compared with adults (Toms et 
al. 2009; Rose et al. 2010; Costa et al. 2014). Given these numbers, average blood levels of 
PBDEs in adults in the United States were in the range of 10-300 ng/g lipid and infant levels 
were reported almost an order of magnitude higher (Costa et al. 2007; Toms et al. 2009; Rose 
et al. 2010). Assuming a uniform distribution of the compounds in blood, these numbers equal 
steady state PBDE concentrations in the range of 10-100 nM in blood (Costa et al. 2014). 
Considering their lipophilicity, accumulation of PBDEs in lipid-rich tissues such as the brain, 
kidneys, liver or fat thus can easily lead to local concentrations in the low micromolar range 
and hence are in the range of the concentrations tested in this work.  
 
Epidermal uptake of organophosphorus flame retardants 
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Recent pharmacokinetic calculations indicated that dermal uptake represents the second most 
important contributor to PBDE body burden, only exceeded by uptake via ingestion (Abdallah 
et al. 2015). DOPO and its bis-DOPO derivatives are additives and hence are not covalently 
bound to their host material, implying an inherent tendency for volatilization. Considering 
their primary use in plastic materials, processed in everyday consumer products such as 
household appliances or furniture, dermal contact with DOPO derivatives will play a central 
role following the introduction into the market. We therefore investigated the influence of the 
different DOPO-derivatives on the integrity of a three-dimensional in vitro epidermal model, 
their penetration potential, and their cytotoxic potential when in contact with cultured 
keratinocytes. Apical application of flame retardants at concentrations of up to 200 mM (in 
5% DMSO in PBS) resulted in no apparent disintegration of the epidermal architecture. The 
Stratum corneum represents the outermost layer of the epidermis and consists of nucleus- and 
organelle-free corneocytes that are constantly replaced by desquamation. Direct contact of the 
flame retardants with the Stratum corneum apparently had no influence on its integrity, but 
evoked the question on the influence of the flame retardants when in contact with organelle-
containing cells of the Stratum granulosum or Stratum spinosum. In order to address this 
question, we first analyzed how deep apically applied flame retardants can penetrate an intact 
epidermis. Analysis by Raman microscopy indicated a detectable penetration of ETA-DOPO 
and to a lesser extent of PBDE-99 into porcine skin with a maximal penetration depth of less 
than 10 µm. The Stratum corneum has an average depth of 20-40 µm. These findings hence 
indicate that penetration of externally applied flame retardants can be efficiently deferred by 
the Stratum corneum, however it has to be considered that the incubation interval employed in 
Fig. 3b was limited to only 1 h in contrast to the chronic exposure with flame retardants under 
everyday conditions. The assessment of the toxicity of EDA-DOPO, ETA-DOPO, and EG-
DOPO in a two-dimensional keratinocyte cell culture model revealed IC50 values (Fig. 3c) for 
the respective flame retardants that were comparable to our observations in macrophages or 
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lung epithelial cells (Fig. 2). These high concentrations are rather unlikely to occur by 
exposure to ambient air and household dust. Furthermore, in a living organism, penetrated 
compounds are continuously distributed by the vascular system. By taking these 
considerations into account, it can be concluded that a direct harmful influence of the flame 
retardants tested in this study on epithelial barriers plays only a neglectable role. However, the 
observed import of extracorporal flame retardants via the skin apparently represents a 
potential route for their uptake which is an essential parameter in the evaluation of their safety 
profile.  
 
Neurotoxic potential of DOPO-derivatives 
Studies on the harmful potential of polybrominated flame retardants highlighted their explicit 
adverse influence on the neuronal system (Costa et al. 2007, 2014). Exposure to PBDE’s in 
the early development of test animals indicated signs of slower motor skill development, an 
influence on synaptic plasticity, and changes in hippocampal long term potentiation in rats 
and mice (Viberg et al. 2006; Dingemans et al. 2007; Ta et al. 2011). Recent human 
epidemiological studies confirmed a correlation between early development exposure to 
various PBDEs and a reduction in psychomotor development, motorfunction, and IQ in 
childhood age (Chevrier et al. 2010; Herbstman et al. 2010; Chao et al. 2011; Gump et al. 
2014). Plasma levels of PBDE’s detected in these studies were usually not associated with 
acute neurodegenerative events. Brain development in its early stages however is 
characterized by timely and spatially tightly regulated phases of precursor proliferation, 
migration, and differentiation. It hence can be assumed that only moderate interferences by 
environmental toxicants in these stages might lead to miswiring of neuronal circuits, or to 
changes in the ratio between different neuronal types. This would prefer levels of particular 
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neurotransmitters at the expense of others, as shown for an inhibition of the cholinergic 
system which is involved in learning and memory (Viberg et al. 2003).  
Based on these observations in the literature, we applied a series of in vitro test systems to 
study the potential harmful influence of the organophosphate flame retardants on the integrity 
of differentiated and differentiating neurons of the central and peripheral nervous system and 
on the influence on neural crest cell migration. In our previous studies on in vitro 
neurodegeneration, we elaborated the quantitative assessment of total neurite mass and the 
migration of mitochondria in neurites as readouts that displayed a far more pronounced 
sensitivity compared to standard cytotoxicity assays such as resazurin or MTT reduction or 
the LDH release assay. Interestingly, both neurite integrity and mitochondrial migration in a 
concentration- and time-dependent manner closely reflected the decline in central and 
peripheral neuron viability detected by resazurin reduction, LDH release, or uptake of calcein-
AM (Fig. 4 + 5) (Suppl. Fig. 10). Furthermore, the concentration-dependent toxicity evoked 
by ETA-DOPO and EG-DOPO in the neuronal models occurred in a modestly lower 
concentration range compared with the non-neuronal models applied in Fig. 2 and 3. In both 
models of central and peripheral nervous system neurons, comparable profiles of cell damage 
and toxicity were observed in fully differentiated cells and when the cells were exposed 
during differentiation (Fig. 4) (Suppl. Fig. 7 + 8 + 9). In contrast to that, and in agreement 
with previous reports in the literature, PBDE-99 exhibited a distinct neurotoxic potential with 
a detrimental influence on central and peripheral neurons at concentrations > 10 µM while in 
non-neuronal models such as macrophages, lung epithelial cells, or keratinocytes, no 
significant toxicity up to 400 µM was observed. These findings clearly illustrate that DOPO 
and its derivatives possess a rather cell type independent toxicity profile. Previous reports on 
the damage evoked by PBDEs in the nervous system not only highlighted their influence on 
neuronal differentiation, but also the influence on neural precursor cell migration (Zimmer et 
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al. 2014). An inappropriate migration of precursor cells in early brain development would 
entail significant disturbance in neuronal function. DOPO and EDA-DOPO exhibited neither 
an influence on neural crest cell migration nor on their viability at concentrations up to 100 
µM. Both ETA-DOPO and EG-DOPO affected cell viability in the same concentration range 
as observed with the assays applied in Figs. 2,3,4, and 5. Interestingly, human neural crest 
cells displayed no decline of viability up to 100 µM PBDE-99 (Fig. 6) in contrast to the 
compound’s influence on differentiating or fully differentiated central- and peripheral neurons 
(Fig. 4 + 5). Migration of these neural crest cells however was inhibited by PBDE-99. These 
observations were fully corroborated by a previous report utilizing murine neural crest cells 
(Zimmer et al. 2014), in which an inhibition of migration in the absence of cell death in a 
concentration range of up to 100 µM was observed. It was not the scope of the present work 
to investigate the selective neurotoxicity of PBDE-99, however the data provided herein and 
in the literature indicate an interaction with neuro-selective targets that are expressed after the 
migration of immature neurons to their ultimate position in the brain, but before an outgrowth 
of neurites is inhibited.  
The present work represents the first toxicological assessment of the DOPO-derivatives EDA-
DOPO, ETA-DOPO, and EG-DOPO with an explicit focus on cellular in vitro models. The 
comparison with PBDE-99 as a representative example for the class of polybrominated 
diphenyl ethers convincingly demonstrated that ETA-DOPO and EG-DOPO possess cell-type 
independent cytotoxic properties at concentrations > 10 µM while DOPO and EDA-DOPO 
display no comparable effect at concentrations higher than 100 µM as can be deduced from 
the graphical summary of all IC50 values calculated from the experiments of this work (Fig. 
7). The herein provided information now allows a targeted design of in vivo experiments 
addressing questions on the compound’s uptake, distribution, and accumulation in different 
organs and tissues, as well as their influence on developmental processes. A combination of 
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the present in vitro data with in vivo observations in test animals would provide a solid 
platform for a qualified initial assessment of the adverse potential of the DOPO-derivatives 
EDA-DOPO, ETA-DOPO, and EG-DOPO when exposed to man.  
Figure Legends 
Fig. 1 (a) Structures of 9,10-dihydro-9-oxa-10-phosphaphenanthrene-10-oxide (DOPO) and 
the novel bridged DOPO derivatives EDA-DOPO, ETA-DOPO, and EG-DOPO. The 
derivatives are characterized by variations in the heteroatom attached to the phosphorus center 
of the respective DOPO monomer, comprising two phosphate- (EG-DOPO), two 
phosphoramidate- (EDA-DOPO), or a combination of phosphate- and phosphoramidate- 
moieties. (b) UL-94 horizontal burning fire test. The respective flame retardants were added 
to polyurethane foam at the concentrations as indicated. The concentration in the host material 
was based on the weight of polyol used in the manufacturing process of polyurethane foams. 
The density of the polyurethane foam was approximately 50 kg/m3. Based on the inherent 
reactivity of DOPO, its final concentration in the foam was limited to 5 %. UL-94 horizontal 
rating classification: HF 1 > HF 2 > HBF > no rating. TCPP (Tris(2-
chlorisopropyl)phosphate) and TCEP (Tris-(2-chlorethyl) phosphate ) were included in the 
fire tests as representative examples of widely applied chlorophosphates.  
 
Fig. 2 Determination of acute cytotoxicity. Human alveolar epithelial cells (A549) and human 
monocytes (THP-1), differentiated into macrophages, were treated with the various flame 
retardants for 48 h. Viability was detected by following the reduction of the tetrazolium 
compound MTS. All data are mean  SD (n=3) *p < 0.05. 
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Fig. 3 Interaction of DOPO-derivatives with epidermal barriers. (a) Influence of flame 
retardants on epidermal integrity. The air-exposed Stratum corneum of a 3D epidermal in 
vitro model generated from primary human keratinocytes was topically exposed to the various 
flame retardants (200 mM) for 48 h, SDS served as positive control. The tissues were then 
fixed, sliced and stained with hematoxiline and eosine in order to allow a discrimination of 
the different epidermal layers. The loose layer beneath the Stratum basale represents the filter 
membrane. (b) Penetration of flame retardants into skin. For the assessment of quantitative 
penetration profiles, porcine skin was topically exposed to the various flame retardants (400 
µM) for 1 h. Confocal Raman microscopy was then applied to obtain a depth profile for each 
compound. The graph illustrates the amount of the respective flame retardants and the 
positive control caffeine relative to keratin content as a function of depth.  (c) Keratinocyte 
sensitization. To determine the skin sensitization potential of the flame retardants tested, 
human HaCaT keratinocytes were stably transfected with a construct coding for the luciferase 
gene under control of the antioxidant response element (ARE) that is activated upon exposure 
of the cells with electrophilic compounds. Luciferase activity was detected after a 2 day 
incubation period with the various flame retardants in the concentrations as indicated. 
Benzylidine acetone served as positive control. In parallel, viability of the cells was assessed 
by the PrestoBlue® reduction assay. All data are mean  SD (n=3) *p < 0.05.  
 
Fig. 4 Toxicity in neurons of the central nervous system.  (a) Mature human dopaminergic 
neurons (LUHMES) were treated with the different flame retardants for 48h from day 6 to day 
8 of LUHMES differentiation as indicated in scheme (b). Cell morphology was visualized by 
fixation and staining of the cells with an anti-β-III-tubulin antibody (yellow), nuclear DNA 
was stained with Hoechst H-33342 (blue). (c) For quantitative assessment of total neurite 
mass, cells were analysed by an automated microscope system with an imaging algorithm 
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allowing a dissimilation between cell bodies and cell extensions. The graph represents the 
total neurite mass detected following the respective treatments. All data are mean  SD (n=3) 
*p < 0.05.  
Fig. 5 Toxicity in neurons of the peripheral nervous system. (a) Differentiation scheme for the 
generation of human dorsal root ganglia-like cells. The pluripotent stem cell line hESC-H9 
was differentiated in a 2-step scheme into peripheral neurons. (b) Flame retardants were 
applied at DoD 3 (Days of Differentiation) post thawing for a period of 48 h, neurite 
outgrowth was investigated by staining of the cells with calcein-AM (cell morphology) and 
Hoechst 33342 (nuclei). (c) Quantitative assessment of cell numbers, as well as of neurite 
mass was conducted with an automated microscope system. Image analysis was performed 
with optimized algorithms allowing the detection of cell numbers by counting of nuclei. 
Neurite growth was quantitatively assessed by detection of the entire calcein signal subtracted 
by a defined area surrounding the nucleus defined as cell body. Data are mean  SD (n=3) 
*p< 0.05. 
 
Fig. 6 Influence of flame retardants on neural crest cell migration. (a) Neural crest cells were 
differentiated from the human embryonic stem cell line hESC-H9. The two images of control 
and EG-DOPO treated cells illustrate the general principle of the assay. The area inside the 
imaginary dotted ring is covered in the beginning by silicone inserts while cells are seeded 
into the surrounding area. Following removal of the inserts, cells are allowed to migrate into 
the cell-free area. For the delineation and identification of single cells, nuclei were stained 
with Hoechst-33342 (blue), cell bodies were stained with calcein (green). For better 
visualization, areas of blue and green overlay were depicted in red. (b) Detection of migration 
and cell viability. Following removal of the stoppers, cells were allowed to migrate in the 
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presence of the flame retardants for 24 h. The number of cells within the imaginary ring was 
detected and compared to the cell number in the entire well to assess a contribution by cell 
proliferation events. Viability was detected by comparison of the number of calcein-positive 
cells with the total cell number in the well. Data are mean  SD (n=3) *p < 0.05. 
Fig. 7 Synopsis of IC50 values. The plot summarizes the IC50 values obtained from the assays 
applied in this work. In the in vitro assays, maximal flame retardant concentrations were 
limited to 400 µM given a maximal residual DMSO concentration of 0.1 %. Due to this 
limitation, for some compounds no IC50 values were assessed. Calculated IC50 values are 
illustrated on the lower segment of the plot. The data points at the top of the plot indicate that 
a clear toxicity was not observed at test concentrations of 100-400 µM. n.d.: not determined. 
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